Intuitive Surgical, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ISRG research report →
About the company
Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets.
- CEO
- David J. Rosa
- IPO
- 2000
- Employees
- 15,638
- HQ
- Sunnyvale, CA, US
Price Chart
- Market Cap
- $145.92B
- P/E
- 49.08
- P/S
- 13.79
- P/B
- 8.37
- EV/EBITDA
- 38.28
- Div Yield
- 0.00%
- Gross Margin
- 66.29%
- Op Margin
- 30.45%
- Net Margin
- 28.15%
- ROE
- 17.01%
- ROIC
- 16.49%
- Revenue
- $10.06B · 20.51%
- Net Income
- $2.86B · 22.97%
- EPS
- $8.00 · 22.32%
- Op Income
- $2.95B
- FCF YoY
- 91.03%
- 52W High
- $603.88
- 52W Low
- $396.68
- 50D MA
- $446.12
- 200D MA
- $492.83
- Beta
- 1.45
- Avg Volume
- 2.17M
Get TickerSpark's AI analysis on ISRG
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 8, 26 | Brosius Mark | sell | 23 |
| Jun 9, 26 | Brosius Mark | sell | 23 |
| Jun 10, 26 | Brosius Mark | sell | 23 |
| Jun 10, 26 | LOEB GARY | sell | 400 |
| Jun 10, 26 | Rosa David J. | other | 1,358 |
| Jun 10, 26 | Rosa David J. | other | 674 |
| Jun 10, 26 | Rosa David J. | other | 1,358 |
| Jun 1, 26 | Jeddi Iman | other | 5,625 |
| Jun 1, 26 | Jeddi Iman | sell | 5,625 |
| Jun 1, 26 | Jeddi Iman | other | 5,625 |
Our ISRG coverage
Recent articles, reports, and earnings notes.
Intuitive Surgical (ISRG): Premium Growth With da Vinci 5
Intuitive Surgical is still compounding through mid-teens procedure growth, rising da Vinci 5 adoption, and a highly recurring revenue mix. The stock looks like a quality-growth name with strong execution, but valuation remains rich.
Intuitive Surgical, Inc. (ISRG) drops 6.5% on valuation
Intuitive Surgical, Inc. (ISRG) drops sharply as investors rotate out of expensive healthcare growth stocks. The company’s fundamentals remain strong after a solid Q1 2026 report, but its premium valuation and margin concerns are pressuring the shares today.
Intuitive Surgical, Inc. (ISRG) rises after Q1 earnings beat
Intuitive Surgical, Inc. (ISRG) rises after a strong Q1 2026 report topped profit and revenue expectations and lifted full-year procedure guidance. The move reflects investor confidence in the company’s recurring revenue model, durable demand for da Vinci systems, and continued growth in robotic-assisted surgery.
Want a deeper read on ISRG?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Similar companies
Peers in the same neighborhood.